Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases

BACKGROUND: In breast cancer current guidelines do not recommend the routine use of serum tumour markers. Differently, we observed that CEA-TPA-CA15.3 (carcinoembryonic (CEA) tissue polypeptide (TPA) and cancer associated 115D8/DF3 (CA15.3) antigens) panel permits early detection and treatment for m...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolini, Andrea, Tartarelli, Gianna, Carpi, Angelo, Metelli, Maria Rita, Ferrari, Paola, Anselmi, Loretta, Conte, Massimo, Berti, Piero, Miccoli, Paolo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1684262/
https://www.ncbi.nlm.nih.gov/pubmed/17116247
http://dx.doi.org/10.1186/1471-2407-6-269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1684262/
https://www.ncbi.nlm.nih.gov/pubmed/17116247
http://dx.doi.org/10.1186/1471-2407-6-269

Ejemplares similares